journal
https://read.qxmd.com/read/37693228/brain-atrophy-as-an-outcome-of-disease-modifying-therapy-for-remitting-relapsing-multiple-sclerosis
#1
REVIEW
Magdalena Chylińska, Jakub Komendziński, Adam Wyszomirski, Bartosz Karaszewski
INTRODUCTION: Currently, clinical trials of DMTs strive to determine their effect on neuroinflammation and neurodegeneration. We aimed to determine the impact of currently used DMTs on brain atrophy and disability in RRMS. The main goal of this review is to evaluate the neuroprotective potential of MS therapy and assess its impact on disability. METHODS: We performed a systematic analysis of clinical trials that used brain atrophy as an outcome or performed post hoc analysis of volumetric MRI parameters to assess the neuroprotective potential of applied therapies...
2023: Multiple Sclerosis International
https://read.qxmd.com/read/37600498/cognitive-contributors-of-backward-walking-in-persons-with-multiple-sclerosis
#2
JOURNAL ARTICLE
Taylor N Takla, Alexis N Chargo, Ana M Daugherty, Nora E Fritz
PURPOSE: Individuals with multiple sclerosis (MS) are at an increased fall risk due to motor and cognitive dysfunction. Our past studies suggest that backward walking (BW) velocity predicts fall risk; however, specific cognitive domains associated with BW velocity remain understudied. The goal of this study was to determine the specific contributions of cognitive functioning to BW velocity in persons with MS. We hypothesized that better visuospatial memory, verbal immediate recall, and faster information processing speed would contribute to faster BW velocity, and deficits in these domains would partially account for disease severity-related impairment in BW velocity...
2023: Multiple Sclerosis International
https://read.qxmd.com/read/36844028/patient-and-clinician-perspectives-of-physical-therapy-for-walking-difficulties-in-multiple-sclerosis
#3
JOURNAL ARTICLE
Prudence Plummer, Andrea Stewart, Jessica N Anderson
Gait speed is frequently the primary efficacy endpoint in clinical trials of interventions targeting mobility in people with multiple sclerosis (MS). However, it is unclear whether increased gait speed is a meaningful outcome for people living with MS. The purpose of this study was to identify the most important aspects of mobility for people with MS and physical therapists and to explore how patients and clinicians perceive whether physical therapy has been effective. Forty-six people with MS and 23 physical therapy clinicians participated in a focus group, one-on-one interview, or electronic survey...
2023: Multiple Sclerosis International
https://read.qxmd.com/read/36536783/is-celiac-disease-cd-prevalent-in-patients-with-multiple-sclerosis-ms-a-systematic-review-and-meta-analysis
#4
REVIEW
Hamide Olfati, Hamed Ghoshouni, Narges Ebrahimi, Aida Mohammadi, Mahsa Ghajarzadeh
BACKGROUND: Celiac disease (CD) is an autoimmune disease, and its prevalence reported variously in different studies. The goal of this study is to evaluate the pooled prevalence of CD in subjects with MS. METHODS: PubMed, Scopus, EMBASE, Web of Science, and Google Scholar along with gray literature were systematically searched. The search included all relevant studies which were published up to October 2022. Two researchers independently searched all databases and also references of included studies...
2022: Multiple Sclerosis International
https://read.qxmd.com/read/36187599/association-of-disease-modifying-therapies-with-covid-19-susceptibility-and-severity-in-patients-with-multiple-sclerosis-a-systematic-review-and-network-meta-analysis
#5
REVIEW
Mahdi Barzegar, Shakiba Houshi, Erfan Sadeghi, Mozhgan Sadat Hashemi, Ghasem Pishgahi, Sara Bagherieh, Alireza Afshari-Safavi, Omid Mirmosayyeb, Vahid Shaygannejad, Aram Zabeti
BACKGROUND: We conducted this study to assess the effect of disease-modifying therapies (DMTs) on coronavirus disease (COVID-19) susceptibility and severity in people with multiple sclerosis (MS). METHODS: Available studies from PubMed, Scopus, EMBASE, Web of Science, and gray literature, including reference lists and conference abstracts, were searched from December 1, 2019, to July 26, 2021. We included cross-sectional, case-control, and cohort studies assessing the association of DMTs with risk of contracting COVID-19 or its outcomes in MS patients on univariate or multivariate regression analyses...
2022: Multiple Sclerosis International
https://read.qxmd.com/read/35860179/the-effectiveness-of-physiotherapy-interventions-for-mobility-in-severe-multiple-sclerosis-a-systematic-review-and-meta-analysis
#6
JOURNAL ARTICLE
Tarub Binshalan, Krishnan Padmakumari Sivaraman Nair, Alisdair McNeill
Background: People with Multiple Sclerosis (pwMS) prioritise gait as the most valuable function to be affected by MS. Physiotherapy plays a key role in managing gait impairment in MS. There is little evidence on the effectiveness of physiotherapy for severe MS. Objective: To undertake a systematic review and meta-analysis of the literature to identify evidence for the effectiveness of physiotherapy for gait impairment in severe MS . Methods . The available literature was systematically searched, using a predetermined protocol, to identify research studies investigating a physiotherapy intervention for mobility in people with severe MS (EDSS ≥ 6...
2022: Multiple Sclerosis International
https://read.qxmd.com/read/35754431/disability-and-fatigue-in-multiple-sclerosis-can-rehabilitation-improve-them-through-a-structured-retraining-program
#7
JOURNAL ARTICLE
María José Arriaza, Azanzazu Vazquez, Teresa Hernández, David Varillas-Delgado, Virginia Meca-Lallana
Functional rehabilitation programs in multiple sclerosis have demonstrated their efficacy in improving fatigue. The assessment of functional impairment, however, is more difficult. The purpose is to assess fatigue and disability as a first study measure and to verify their improvement after a specific functional rehabilitation program. An analytical, longitudinal, prospective, and experimental study was carried out with 51 patients aged 18-55 years, with an Expanded Disability Status Scale (EDSS) between 2 and 6...
2022: Multiple Sclerosis International
https://read.qxmd.com/read/35345609/incidence-and-prevalence-of-multiple-sclerosis-in-malm%C3%A3-southern-sweden
#8
JOURNAL ARTICLE
Lucía Alonso-Magdalena, Elisabet Zia, Olga Carmona I Codina, Hélène Pessah-Rasmussen, Peter Sundström
Objectives: To estimate the incidence and prevalence of multiple sclerosis (MS) in Malmö municipality in southwestern Sweden. Materials and Methods: Multiple sources were used in the case identification process. Case ascertainment was assessed by medical chart review including examinations such as magnetic resonance imaging, cerebrospinal fluid analyses, and relevant laboratory tests. Cases were classified according to the 2010 McDonald's diagnostic criteria. Onset-adjusted prevalence and a definition of onset symptoms were applied...
2022: Multiple Sclerosis International
https://read.qxmd.com/read/35281348/telehealth-delivered-cognitive-behavioral-therapy-for-insomnia-in-individuals-with-multiple-sclerosis-a-pilot-study
#9
JOURNAL ARTICLE
David Turkowitch, Rebecca Ludwig, Eryen Nelson, Michelle Drerup, Catherine F Siengsukon
Background: Over 50% of individuals with multiple sclerosis (MS) have moderate or severe sleep disturbances, insomnia being the most common. In-person cognitive behavioral therapy for insomnia (F2F-CBTi) is currently the first-line treatment for insomnia. However, given potential limitations to access including mobility difficulty, fatigue, or living in a rural area, telehealth-delivered CBT-I (tele-CBTi) has been considered as an alternative treatment. The purpose of this study was to assess the feasibility and treatment effect of tele-CBTi in people with MS and compare it to outcomes from a F2F-CBTi study in individuals with MS...
2022: Multiple Sclerosis International
https://read.qxmd.com/read/34796030/prevalence-of-pediatric-onset-multiple-sclerosis-in-saudi-arabia
#10
JOURNAL ARTICLE
Reem Bunyan, Ghada Al Towaijri, Hessa Al Otaibi, Abid Kareem, Hussein Algahtani, Mousa Al Mejally, Ali Almubarak, Saad Alrajeh, Edward Cupler, Shireen Qureshi, Sadaga Alawi, Mamdouh Kalakatawi, Yaser Al Malik, Shahpar Nahrir, Adel Alhazzani, Ashraf El-Metwally, Sahar Shami, Samah Ishak, Hajer Almudaiheem, Ahmed Al-Jedai, Mohammed AlJumah
Background: The prevalence of multiple sclerosis (MS) appears to be increasing worldwide. However, data on the pediatric onset of MS is lacking, particularly in developing countries. Objective: This study is aimed at reporting the current burden of the pediatric onset of MS in the five regions of Saudi Arabia. Methods: This study used relevant data from the National Saudi MS Registry that was operational between 2015 and 2018. The data on patients with pediatric onset MS from all the hospitals included in the registry was retrospectively analyzed using the age of diagnosis...
2021: Multiple Sclerosis International
https://read.qxmd.com/read/34621549/aquaporin-4-autoantibody-detection-by-elisa-a-retrospective-characterization-of-a-commonly-used-assay
#11
JOURNAL ARTICLE
Jon P Williams, Justin R Abbatemarco, Jonathan J Galli, Stefanie J Rodenbeck, Lisa K Peterson, Thomas R Haven, Meagan Street, John W Rose, John E Greenlee, M Mateo Paz Soldan, Stacey L Clardy
OBJECTIVE: Aquaporin-4 (AQP4) serum autoantibodies are detected by a variety of methods. The highest sensitivity is achieved with cell-based assays, but the enzyme-linked immunosorbent assay (ELISA) is still commonly utilized by clinicians worldwide. METHODS: We performed a retrospective review to identify all patients at the University of Utah who had AQP4 ELISA testing at ARUP Laboratories from 2010 to 2017. We then reviewed their diagnostic evaluation and final diagnosis based on the ELISA titer result...
2021: Multiple Sclerosis International
https://read.qxmd.com/read/34327022/a-tripartite-knowledge-translation-program-innovative-patient-centered-approach-to-clinical-research-participation-for-individuals-with-multiple-sclerosis
#12
JOURNAL ARTICLE
Aman Saini, Colleen Cochran, Audrey Zucker-Levin, Sarah J Donkers, Pawan Kumar, Katherine B Knox, Jessica MacPherson, Hannah Salapa, Michael C Levin
Background: Knowledge translation (KT) models that represent an individual's perspective are a sign of effective KT. Some common challenges in KT include participant engagement, organization of the team, and time demands of the participants. We implemented a unique tripartite KT program to (1) share current research, (2) inform persons living with multiple sclerosis (pwMS) about the clinical research process, and (3) invite pwMS to immediately participate in clinical research. The primary aim was to determine participants' perspectives on the value and acceptability of an experiential research program offered at a patient and family educational conference...
2021: Multiple Sclerosis International
https://read.qxmd.com/read/34327021/state-of-the-art-review-demyelinating-diseases-in-indonesia
#13
REVIEW
Hana Larassati, Riwanti Estiasari, Reyhan E Yunus, Paul M Parizel
Demyelinating diseases are more common in Indonesia than previously believed. However, it is still a challenge for a country such as Indonesia to implement the scientific medical advances, especially in the diagnostic process of demyelinating diseases, to achieve the best possible outcome for these groups of patients, within the constraints of what is socially, technologically, economically, and logistically achievable. In this review, we address the 4 major classes of demyelinating disease: multiple sclerosis (MS), neuromyelitis optica (NMO), anti-MOG-associated encephalomyelitis (MOG-EM), and acute disseminated encephalomyelitis (ADEM), and discuss their prevalence, demographics, clinical diagnosis workup, and imaging features in the Indonesian population, as well as the challenges we face in their diagnosis and therapeutic approach...
2021: Multiple Sclerosis International
https://read.qxmd.com/read/34306756/quantitative-magnetic-resonance-imaging-analysis-of-early-markers-of-upper-cervical-cord-atrophy-in-multiple-sclerosis-and-neuromyelitis-optica-spectrum-disorder
#14
JOURNAL ARTICLE
Iman Adibi, Afshin Najafi, Fouad Merajifar, Neda Ramezani, Hosein Nouri, Nassim Jalilvand, Fereshteh Ashtari, Alireza Vard, Vahid Shaygannejad
PURPOSE: To quantitatively analyze the C2/C3 segments of the spinal cord on magnetic resonance imaging (MRI) scans of neuromyelitis optica spectrum disorder (NMOSD) and relapsing-remitting multiple sclerosis (RRMS) patients in their first five years of the disease and to investigate the intergroup differences regarding markers of spinal cord atrophy and their correlations with expanded disability status scale (EDSS). MATERIALS AND METHODS: Twenty NMOSD patients and twenty RRMS patients, within their first five years of the disease, were enrolled in this cross-sectional study...
2021: Multiple Sclerosis International
https://read.qxmd.com/read/34258067/a-descriptive-correlational-study-to-evaluate-three-measures-of-assessing-upper-extremity-function-in-individuals-with-multiple-sclerosis
#15
JOURNAL ARTICLE
Aman Saini, Audrey Zucker-Levin, Benjamin McMillan, Pawan Kumar, Sarah Donkers, Michael C Levin
Background: Activities of daily living and quality of life (QOL) are hindered by upper extremity (UE) impairments experienced by individuals with multiple sclerosis (iMS). The Nine-Hole Peg Test (9-HPT) is most frequently used to measure UE function. However, it does not measure peoples' ability to perform routine tasks in daily life and may not be useful in iMS who cannot pick up the pegs utilized in the 9-HPT. Therefore, we evaluated three measures to explore a more comprehensive assessment of UE function: Upper Extremity Function Scale (UEFS), Action Research Arm Test (ARAT), and the 9-HPT...
2021: Multiple Sclerosis International
https://read.qxmd.com/read/34221508/evaluation-of-month-of-birth-in-neuromyelitis-optica-spectrum-disorders-nmsod-and-multiple-sclerosis-ms
#16
JOURNAL ARTICLE
Omid Mirmosayyeb, Mahdi Barzegar, Alireza Afshari-Safavi, Nasim Nehzat, Afshin Heidari, Parisa Emami, Vahid Shaygannejad
Introduction: Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMO) are chronic immune-mediated diseases in the central nervous system (CNS). Environmental factors such as month of birth can be a trigger for these diseases. Therefore, we conducted this study to compare the months of birth in MS and NMOSD patients with the control group. Methods: In this cross-sectional study, 2345 patients with MS, 220 NMOSD patients, and 2174 healthy subjects were enrolled...
2021: Multiple Sclerosis International
https://read.qxmd.com/read/34221507/pulmonary-function-and-respiratory-muscle-strength-in-patients-with-multiple-sclerosis
#17
JOURNAL ARTICLE
Elisabeth Westerdahl, Martin Gunnarsson, Anna Wittrin, Ylva Nilsagård
Background: In patients with multiple sclerosis (MS), there is a decline in muscle strength and physical capacity due to demyelination and axonal loss in the central nervous system. In patients with advanced MS or in a later stage of the disease, also respiratory impairment may occur. The degree of pulmonary dysfunction in the earlier stages of MS has not been thoroughly described. Therefore, the primary aims of this study are to describe pulmonary function and respiratory muscle strength in patients with a moderate disease course and to identify associations between respiratory muscle strength and functional capacity...
2021: Multiple Sclerosis International
https://read.qxmd.com/read/34123428/risk-factors-associated-with-multiple-sclerosis-a-case-control-study-in-damascus-syria
#18
JOURNAL ARTICLE
Maher Taan, Farah Al Ahmad, Mohammad Karim Ercksousi, Ghassan Hamza
Objectives: To assess the probable risk factors associated with Multiple sclerosis among Syrian patients in the city of Damascus. Method: In a case-control study conducted from May to September 2020, 140 MS patients and 140 healthy controls were selected from two main hospitals in Damascus. Data regarding risk factors associated with MS was collected via a structured questionnaire and complementary laboratory tests. The statistical analysis was carried out by the SPSS Statistical Software Version 26...
2021: Multiple Sclerosis International
https://read.qxmd.com/read/34123427/speed-but-not-smoothness-of-gait-reacts-to-rehabilitation-in-multiple-sclerosis
#19
JOURNAL ARTICLE
Philipp Gulde, Joachim Hermsdörfer, Peter Rieckmann
Introduction: Improved gait is one of the leading therapy goals in multiple sclerosis. A plethora of clinical timed trials and state-of-the-art technology-based approaches are available to assess gait performance. Objectives: To examine what aspects of gait react to inpatient rehabilitation in MS and which parameters should be best assessed. Design: In this longitudinal study, we examined the performance of 76 patients with MS to shed further light on factors influencing gait, associations between tests, and the reaction to inpatient rehabilitation during an average time span of 16 d...
2021: Multiple Sclerosis International
https://read.qxmd.com/read/33763241/no-early-effect-of-intrathecal-rituximab-in-progressive-multiple-sclerosis-effrite-clinical-trial
#20
JOURNAL ARTICLE
Mickael Bonnan, Sylvie Ferrari, Henri Courtade, Paul Money, Pauline Desblache, Bruno Barroso, Stéphane Debeugny
BACKGROUND: The progressive phase of multiple sclerosis (MS) is characterized by an intrathecal (IT) compartmentalization of inflammation, involving B-cells within meningeal follicles, and resisting all the available immunosuppressive treatments. A new therapeutic paradigm may be to target this inflammation by injecting immunosuppressive drugs inside the central nervous system compartment. METHODS: We designed a single-center, open-label, randomized, controlled, phase II study designed to evaluate the safety and efficacy of IT rituximab in progressive MS (EFFRITE trial; ClinicalTrial Registration NCT02545959)...
2021: Multiple Sclerosis International
journal
journal
43705
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.